TOPLINE Drugmakers Pfizer and BioNTech asked U.S. regulators on Friday to make their Covid-19 vaccine the first authorized for Americans under the age of 16, after preliminary data suggested the shot is 100% effective at staving off illness in teens ages 12 to 15. KEY FACTS New York City-based Pfizer and Germany’s BioNTech are asking...
Tag: <span>COVID vaccine</span>
Post
BioNTech-Pfizer say COVID vaccine 100% effective on 12-15 year olds
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year. Phase 3 trials carried out on 2,260 adolescents in the United States “demonstrated 100 percent efficacy and robust antibody responses”, the companies...
Post
If You Don’t Have COVID Vaccine Side Effects, Are You Still Protected?
By Stephani Sutherland on April 1, 2021 Credit: Jasmin Merdan Getty Images Last month Robert Duehmig and Bill Griesar—a married couple in their 50s who live in Astoria, Ore., and Portland, Ore.—were each relieved to get their second shot of the Pfizer-BioNTech vaccine for COVID-19. After the jab, Griesar felt nothing more than a sore arm. But for Duehmig, the...
Post
A Covid Vaccine Side Effect, Enlarged Lymph Nodes, Can Be Mistaken for Cancer
By Denise Grady March 1, 2021, 3:14 p.m. ET Covid-19 vaccinations at the Community Center in Rohnert Park, Calif. Swelling of lymph nodes in the armpit became a recognized side effect in the trials of the Moderna and Pfizer-BioNTech vaccines.Credit…Jim Wilson/The New York Times Coronavirus vaccinations can cause enlarged lymph nodes in the armpit or near the...
Post
J&J Covid vaccine
By MATTHEW HERPER @matthewherper JANUARY 29, 2021 Reprints MARK RALSTON/AFP VIA GETTY IMAGES Johnson & Johnson said Friday that its single-dose Covid-19 vaccine reduced rates of moderate and severe disease, but the shot appeared less effective in South Africa, where a new coronavirus variant has become common. Overall, the vaccine was 66% effective at preventing moderate to severe disease...
Post
Johnson & Johnson’s one-dose COVID vaccine promising in early trial
JANUARY 14, 2021 A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts. The vaccine produced an immune response of all 805 clinical trial participants within two months of inoculation, according to results published Jan. 13 in the New England Journal of Medicine. The...
Post
The Best Evidence for How to Overcome COVID Vaccine Fears
By Claudia Wallis on January 7, 2021 Kishore Nath holds a vaccination card provided to residents who have been given the Pfizer COVID-19 vaccine at Viamonte, a retirement community in Walnut Creek, Calif., on December 30, 2020. Credit: Carlos Avila Gonzalez Getty Images Operation Warp Speed has certainly lived up to its name. The arrival of the first coronavirus vaccines...
Post
Asia-Pacific Roundup: India seeks more data on AstraZeneca COVID vaccine
By Nick Paul Taylor India’s Subject Expert Committee (SEC) has asked to see additional data on AstraZeneca’s COVID-19 vaccine before deciding whether to grant emergency use authorization (EUA). The Central Drugs Standard Control Organization (CDSCO) wants to see immunogenicity data from patients in the UK and India and safety data beyond the 14 November cut-off shared...
Post
The COVID vaccine challenges that lie ahead
The University of Oxford and Astra Zeneca have pledged that their COVID vaccine (pictured) will always be available at cost to low and middle income countries. Other developers must make the same commitment. A year on from the first known case of COVID-19, the world has been hungry for good news. This month, vaccine makers...